Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Alzheimer's Disease

  Free Subscription

Articles published in Exp Gerontol

Retrieve available abstracts of 59 articles:
HTML format

Single Articles

    March 2024
  1. HE K, Nie L, Yang C, Liu Z, et al
    Exhaustive exercise decreases tau phosphorylation and modifies biological processes associated with the protein translation and electron transport chain in P301L tau transgenic mice.
    Exp Gerontol. 2024;187:112375.
    PubMed     Abstract available

    February 2024
  2. LIU T, Li N, Pu J, Zhang C, et al
    The plasma derived exosomal miRNA-483-5p/502-5p serve as potential MCI biomarkers in aging.
    Exp Gerontol. 2024;186:112355.
    PubMed     Abstract available

    January 2024
  3. XUE H, Chen J, Zeng L, Fan W, et al
    Causal relationship between circulating immune cells and the risk of Alzheimer's disease: A Mendelian randomization study.
    Exp Gerontol. 2024 Jan 30:112371. doi: 10.1016/j.exger.2024.112371.
    PubMed     Abstract available

  4. DA SILVA RODRIGUES G, Noronha NY, Noma IHY, de Lima JGR, et al
    14-Week exercise training modifies the DNA methylation levels at gene sites in non-Alzheimer's disease women aged 50 to 70 years.
    Exp Gerontol. 2024 Jan 15:112362. doi: 10.1016/j.exger.2024.112362.
    PubMed     Abstract available

    November 2023
  5. TYLISZCZAK M, Wiatrak B, Danielewski M, Szelag A, et al
    Does a pickle a day keep Alzheimer's away? Fermented food in Alzheimer's disease: A review.
    Exp Gerontol. 2023 Nov 13:112332. doi: 10.1016/j.exger.2023.112332.
    PubMed     Abstract available

  6. JOBIN B, Boller B, Frasnelli J
    Smaller grey matter volume in the central olfactory system in mild cognitive impairment.
    Exp Gerontol. 2023;183:112325.
    PubMed     Abstract available

    October 2023
  7. CHEN H, Cai J, Wang A, Su W, et al
    Treadmill exercise prevents the hyperexcitability of pyramidal neurons in medial entorhinal cortex in the 3xTg-AD mouse model of Alzheimer's disease.
    Exp Gerontol. 2023;182:112309.
    PubMed     Abstract available

  8. SUN J, Zhang Z, Yang K, Wei G, et al
    Ameliorative effects of pine nut peptide-zinc chelate (Korean pine) on a mouse model of Alzheimer's disease.
    Exp Gerontol. 2023 Oct 9:112308. doi: 10.1016/j.exger.2023.112308.
    PubMed     Abstract available

    September 2023
  9. LIU S, Zhang S, Guo M, Lei Q, et al
    Acoustic stimulation during sleep improves cognition and ameliorates Alzheimer's disease pathology in APP/PS1 mice.
    Exp Gerontol. 2023;182:112299.
    PubMed     Abstract available

    July 2023
  10. DAI M, Guo Z, Chen J, Liu H, et al
    Altered functional connectivity of the locus coeruleus in Alzheimer's disease patients with depression symptoms.
    Exp Gerontol. 2023;179:112252.
    PubMed     Abstract available

  11. PETRILLO K, Javed B, Toosizadeh N
    Association between dual-task function and neuropsychological testing in older adults with cognitive impairment.
    Exp Gerontol. 2023;178:112223.
    PubMed     Abstract available

    June 2023
  12. LIU B, Lv LL, Liu P, Xu YY, et al
    Proteomic analysis of anti-aging effects of Dendrobium nobile Lindl. alkaloids in aging-accelerated SAMP8 mice.
    Exp Gerontol. 2023;177:112198.
    PubMed     Abstract available

    April 2023
  13. KARAJI ZG, Fathi M, Mirnasori R, van der Zee EA, et al
    Swimming exercise and clove oil can improve memory by molecular responses modification and reduce dark cells in rat model of Alzheimer's disease.
    Exp Gerontol. 2023;177:112192.
    PubMed     Abstract available

  14. WANG T, Zhao W, Liu Y, Yang D, et al
    MicroRNA-511-3p regulates Abeta(1-40) induced decreased cell viability and serves as a candidate biomarker in Alzheimer's disease.
    Exp Gerontol. 2023 Apr 28:112195. doi: 10.1016/j.exger.2023.112195.
    PubMed     Abstract available

    February 2023
  15. AKUSHEVICH I, Yashkin A, Kovtun M, Kravchenko J, et al
    Forecasting prevalence and mortality of Alzheimer's disease using the partitioning models.
    Exp Gerontol. 2023 Feb 24:112133. doi: 10.1016/j.exger.2023.112133.
    PubMed     Abstract available

  16. VERMA AK, Singh S, Rizvi SI
    Aging, circadian disruption and neurodegeneration: Interesting interplay.
    Exp Gerontol. 2023;172:112076.
    PubMed     Abstract available

    January 2023
  17. MALEK-AHMADI M, Duff K, Chen K, Su Y, et al
    Volumetric regional MRI and neuropsychological predictors of motor task variability in cognitively unimpaired, mild cognitive impairment, and probable Alzheimer's disease older adults.
    Exp Gerontol. 2023 Jan 10:112087. doi: 10.1016/j.exger.2023.112087.
    PubMed     Abstract available

    December 2022
  18. ST-MARTIN P, Dionne IJ, Maltais M, Rolland Y, et al
    Cross-sectional and prospective associations between homocysteine and a frailty index: A post-hoc analysis of the multidomain Alzheimer's prevention trial (MAPT).
    Exp Gerontol. 2022 Dec 19:112066. doi: 10.1016/j.exger.2022.112066.
    PubMed     Abstract available

  19. GREGORY S, Pullen H, Ritchie CW, Shannon OM, et al
    Mediterranean diet and structural neuroimaging biomarkers of Alzheimer's and cerebrovascular disease: A systematic review.
    Exp Gerontol. 2022;172:112065.
    PubMed     Abstract available

  20. FUTSCHEK IB, Schernhammer E, Haslacher H, Stogmann E, et al
    Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
    Exp Gerontol. 2022 Dec 9:112045. doi: 10.1016/j.exger.2022.112045.
    PubMed     Abstract available

    November 2022
  21. EZZATI A, Pak VM
    The effects of time-restricted eating on sleep, cognitive decline, and Alzheimer's disease.
    Exp Gerontol. 2022 Nov 17:112033. doi: 10.1016/j.exger.2022.112033.
    PubMed     Abstract available

    October 2022
  22. SAYEHMIRI F, Khodagholi F, Pourbadie HG, Naderi N, et al
    Phosphonate analog of 2-oxoglutarate regulates glutamate-glutamine homeostasis and counteracts amyloid beta induced learning and memory deficits in rats.
    Exp Gerontol. 2022;168:111944.
    PubMed     Abstract available

    September 2022
  23. ABUELEZZ NZ, Nasr FE, Abdel Aal WM, Molokhia T, et al
    Sera miR-34a, miR-29b and miR-181c as potential novel diagnostic biomarker panel for Alzheimers in the Egyptian population.
    Exp Gerontol. 2022;169:111961.
    PubMed     Abstract available

  24. HE X, Yan C, Zhao S, Zhao Y, et al
    The preventive effects of probiotic Akkermansia muciniphila on D-galactose/AlCl3 mediated Alzheimer's disease-like rats.
    Exp Gerontol. 2022 Sep 21:111959. doi: 10.1016/j.exger.2022.111959.
    PubMed     Abstract available

  25. COUTINHO LA, Leao LL, Cassilhas RC, de Paula AMB, et al
    Alzheimer's disease genes and proteins associated with resistance and aerobic training: An in silico analysis.
    Exp Gerontol. 2022 Sep 7:111948. doi: 10.1016/j.exger.2022.111948.
    PubMed     Abstract available

  26. NABIZADEH F, Kankam SB, Balabandian M, Hashemi SM, et al
    Metformin use and brain atrophy in nondemented elderly individuals with diabetes.
    Exp Gerontol. 2022;166:111890.
    PubMed     Abstract available

  27. KAMENO K, Hasegawa Y, Hayashi K, Takemoto Y, et al
    Loss of body weight in old 5xFAD mice and the alteration of gut microbiota composition.
    Exp Gerontol. 2022;166:111885.
    PubMed     Abstract available

    August 2022
  28. PLACIDO J, de Almeida CAB, Ferreira JV, de Oliveira Silva F, et al
    Spatial navigation in older adults with mild cognitive impairment and dementia: A systematic review and meta-analysis.
    Exp Gerontol. 2022;165:111852.
    PubMed     Abstract available

  29. GARCIA-VELAZQUEZ L, Lopez-Carrasco P, Arias C
    Age-dependent changes in Wnt signaling components and synapse number are differentially affected between brain regions.
    Exp Gerontol. 2022;165:111854.
    PubMed     Abstract available

  30. KURAPOVA R, Chouliaras L, O'Brien JT
    The promise of amplification assays for accurate early detection of alpha-synucleinopathies: A review.
    Exp Gerontol. 2022;165:111842.
    PubMed     Abstract available

    July 2022
  31. AKUSHEVICH I, Yashkin AP, Kravchenko J, Kertai MD, et al
    Extended anesthesia exposure for abdominal and pelvic procedures in older adults with colorectal cancer: Associations with chart dementia diagnoses.
    Exp Gerontol. 2022;164:111830.
    PubMed     Abstract available

    May 2022
  32. REISS AB, Ahmed S, Dayaramani C, Glass AD, et al
    The role of mitochondrial dysfunction in Alzheimer's disease: A potential pathway to treatment.
    Exp Gerontol. 2022 May 1:111828. doi: 10.1016/j.exger.2022.111828.
    PubMed     Abstract available

    April 2022
  33. BAZRGAR M, Khodabakhsh P, Dargahi L, Mohagheghi F, et al
    MicroRNA modulation is a potential molecular mechanism for neuroprotective effects of intranasal insulin administration in amyloid betaeta oligomer induced Alzheimer's like rat model.
    Exp Gerontol. 2022;164:111812.
    PubMed     Abstract available

    January 2022
  34. GLASMAN P, Houot M, Migliaccio R, Bombois S, et al
    Subtle postoperative cognitive disorder in preclinical Alzheimer's disease.
    Exp Gerontol. 2022 Jan 29:111715. doi: 10.1016/j.exger.2022.111715.
    PubMed     Abstract available

  35. TARBALI S, Zahmatkesh M, Torkaman-Boutorabi A, Khodagholi F, et al
    Assessment of lipophilic fluorescence products in beta-amyloid-induced cognitive decline: A parallel track in hippocampus, CSF, plasma and erythrocytes.
    Exp Gerontol. 2022;157:111645.
    PubMed     Abstract available

    August 2021
  36. LI P, Wu Q, Li X, Hu B, et al
    Shenqi Yizhi Granule attenuates Abeta1-42 induced cognitive dysfunction via inhibiting JAK2/STAT3 activated astrocyte reactivity.
    Exp Gerontol. 2021;151:111400.
    PubMed     Abstract available

    July 2021
  37. VASCONCELOS-FILHO FSL, da Rocha Oliveira LC, de Freitas TBC, de Pontes PADS, et al
    Effect of involuntary chronic physical exercise on beta-amyloid protein in experimental models of Alzheimer's disease: Systematic review and meta-analysis.
    Exp Gerontol. 2021 Jul 30:111502. doi: 10.1016/j.exger.2021.111502.
    PubMed     Abstract available

  38. VATANABE IP, Pedroso RV, Manzine PR, Chagas MHN, et al
    ADAM10: Biomarker of mild cognitive impairment but not of cognitive frailty.
    Exp Gerontol. 2021;149:111303.
    PubMed     Abstract available

    June 2021
  39. GALLO A, Pillet LE, Verpillot R
    New frontiers in Alzheimer's disease diagnostic: Monoamines and their derivatives in biological fluids.
    Exp Gerontol. 2021;152:111452.
    PubMed     Abstract available

    May 2021
  40. CEZAR NOC, Aprahamian I, Ansai JH, de Oliveira MPB, et al
    Feasibility of reducing frailty components in older adults with Alzheimer's dementia: a randomized controlled home-based exercise trial (AD-HOMEX).
    Exp Gerontol. 2021;150:111390.
    PubMed     Abstract available

  41. LIU L, Cao J, Huang C, Yuan E, et al
    Analysis the alteration of systemic inflammation in old and young APP/PS1 mouse.
    Exp Gerontol. 2021;147:111274.
    PubMed     Abstract available

  42. YANG I, Arthur RA, Zhao L, Clark J, et al
    The oral microbiome and inflammation in mild cognitive impairment.
    Exp Gerontol. 2021;147:111273.
    PubMed     Abstract available

    April 2021
  43. TZEKAKI EE, Tsolaki M, Pantazaki AlphaA, Geromichalos G, et al
    The pleiotropic beneficial intervention of olive oil intake on the Alzheimer's disease onset via fibrinolytic system.
    Exp Gerontol. 2021 Apr 6:111344. doi: 10.1016/j.exger.2021.111344.
    PubMed     Abstract available

    March 2021
  44. XIAO QY, Ye TY, Wang XL, Han L, et al
    A network pharmacology-based study on key pharmacological pathways and targets of Qi Fu Yin acting on Alzheimer's disease.
    Exp Gerontol. 2021 Mar 27:111336. doi: 10.1016/j.exger.2021.111336.
    PubMed     Abstract available

  45. PINI L, Wennberg AM
    Structural imaging outcomes in subjective cognitive decline: Community vs. clinical-based samples.
    Exp Gerontol. 2021;145:111216.
    PubMed     Abstract available

    February 2021
  46. EGASHIRA R, Umezaki Y, Mizutani S, Obata T, et al
    Relationship between cerebral atrophy and number of present teeth in elderly individuals with cognitive decline.
    Exp Gerontol. 2021;144:111189.
    PubMed     Abstract available

    January 2021
  47. FERNANDEZ FX, Kaladchibachi S, Negelspach DC
    Resilience in the suprachiasmatic nucleus: Implications for aging and Alzheimer's disease.
    Exp Gerontol. 2021;147:111258.
    PubMed     Abstract available

  48. BLASKO I, Defrancesco M, Oberacher H, Loacker L, et al
    Plasma phosphatidylcholines and vitamin B12/folate levels are possible prognostic biomarkers for progression of Alzheimer's disease.
    Exp Gerontol. 2021 Jan 28:111264. doi: 10.1016/j.exger.2021.111264.
    PubMed     Abstract available

  49. YAN T, Liu B, Wang N, Liao Z, et al
    The flavonoids of okra insulates against oxidative stress, neuroinflammation and restores BDNF levels in Abeta1-42 induced mouse model of Alzheimer's disease.
    Exp Gerontol. 2021;147:111263.
    PubMed     Abstract available

  50. SOYSAL P, Tan SG, Smith L
    A comparison of the prevalence of Fear of Falling between older patients with Lewy body dementia, Alzheimer's disease, and without dementia.
    Exp Gerontol. 2021;146:111248.
    PubMed     Abstract available

  51. AL-HARRASI AM, Iqbal E, Tsamakis K, Lasek J, et al
    Motor signs in Alzheimer's disease and vascular dementia: Detection through natural language processing, co-morbid features and relationship to adverse outcomes.
    Exp Gerontol. 2021 Jan 12:111223. doi: 10.1016/j.exger.2020.111223.
    PubMed     Abstract available

    December 2020
  52. TZEKAKI EE, Papaspyropoulos A, Tsolaki M, Lazarou E, et al
    Restoration of BMI1 levels after the administration of early harvest extra virgin olive oil as a therapeutic strategy against Alzheimer's disease.
    Exp Gerontol. 2020 Dec 5:111178. doi: 10.1016/j.exger.2020.111178.
    PubMed     Abstract available

  53. LIU Q, Lei C
    Neuroprotective effects of miR-331-3p through improved cell viability and inflammatory marker expression: Correlation of serum miR-331-3p levels with diagnosis and severity of Alzheimer's disease.
    Exp Gerontol. 2020;144:111187.
    PubMed     Abstract available

  54. ZHANG J, Wang R
    Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-beta induced neurotoxicity and neuroinflammation by sponging miR-374b-5p.
    Exp Gerontol. 2020;144:111180.
    PubMed     Abstract available

  55. SCHIMIDT HL, Carrazoni GS, Garcia A, Izquierdo I, et al
    Strength training or green tea prevent memory deficits in a beta-amyloid peptide-mediated Alzheimer's disease model.
    Exp Gerontol. 2020;143:111186.
    PubMed     Abstract available

    September 2020
  56. YADAV J, Verma AK, Garg RK, Ahmad K, et al
    Sialic acid associated with oxidative stress and total antioxidant capacity (TAC) expression level as a predictive indicator in moderate to severe Alzheimer's disease.
    Exp Gerontol. 2020 Sep 26:111092. doi: 10.1016/j.exger.2020.111092.
    PubMed     Abstract available

    April 2020
  57. ELSWORTHY RJ, Aldred S
    The effect of age and obesity on platelet amyloid precursor protein processing and plasma markers of oxidative stress and inflammation.
    Exp Gerontol. 2020;132:110838.
    PubMed     Abstract available

    February 2020
  58. YAN T, Nian T, Wu B, Xiao F, et al
    Okra polysaccharides can reverse the metabolic disorder induced by high-fat diet and cognitive function injury in Abeta1-42 mice.
    Exp Gerontol. 2020;130:110802.
    PubMed     Abstract available

  59. LIN X, Chen Y, Zhang P, Chen G, et al
    The potential mechanism of postoperative cognitive dysfunction in older people.
    Exp Gerontol. 2020;130:110791.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.